Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well from reading the below paragraph from todays RNS there defo looks like there is a possibility of some "potential value generation" from Iclaprim and its sale...
"Jonathan Gold, Motif's President and Chief Business Officer, commented: "The Transaction is an important step to prepare Motif to complete the Reverse Takeover. The Transaction also creates incentives for Orange to focus on the potential generation of value from iclaprim for Motif's shareholders, while allowing Motif to focus on completing the Reverse Takeover with a UK-based ADC (Antibody-Drug Conjugate) discovery and development company."
Don’t let’s forget Iclapim it was much superior then competitors at that time One of them was the Pfizer Vancomycin which did got the thumbs up obviously being from Pfizer made it all there different right!
agree with a lot of that Elsol. i think we can pretty much forget about iclaprim now.we may get something at some time in the future but as you say its not likely to be much and is at best highly speculative. i doubt the RTO candidate will have had any interest in iclaprim as a partial incentive for the deal.it will be all about the listing imo.it is starting to seem quite likely an RTO will go ahead but as a severely wounded survivor from st valentines day, I'm not expecting much personally. those who bought in in anticipation of the RTP or have averaged down may do quite well if we get the right candidate.gla
The only positive here is that this transaction increases the liklihood of THE RTO...clearly the RTO candidate had no strategic ambition in iclaprim and was not prepared to invest further peanuts to continue the marketing of the asset to potential third parties, so the only option was to offload it and pay someone 10% of any revenue upside and 250kUSD milestone if successful. All the new owner has to do is to hold tight a few years and make an occasional informed telephone call. Seems like he got a good deal here. Free option upside with minimal investment ( 1USD + minimal costs for keeping patents going and a bit of time for telephone calls! BUT. It means some upside may comeback to Newco however the benefit (if any ) will be diluted to the RTO party probably materially rather than legacy MTFB. It remains to be seen how much hope value was allocated to this iclaprim upside by the RTO party in respect to our relative value...im not convinced its much im afraid. Let's hope the RTO once launched attracts a good investor ground swell to compensate us poor shareholders and hope for good value added in coming years